These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Phillips MD; Moake JL; Nolasco L; Turner N Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193 [TBL] [Abstract][Full Text] [Related]
43. Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin. Hoylaerts MF; Nuyts K; Peerlinck K; Deckmyn H; Vermylen J Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):453-63. PubMed ID: 7887899 [TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium. Kroll MH; Mendelsohn ME; Miller JL; Ballen KK; Hrbolich JK; Schafer AI Biochim Biophys Acta; 1992 Nov; 1137(3):248-56. PubMed ID: 1332779 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers. Zucker MB; Puszkin EG; Sussman II; Mauss EA J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846 [TBL] [Abstract][Full Text] [Related]
46. Glycoprotein IIb-IIIa-dependent aggregation by glycoprotein Ibalpha is reinforced by a Src family kinase inhibitor (PP1)-sensitive signalling pathway. Marshall SJ; Asazuma N; Best D; Wonerow P; Salmon G; Andrews RK; Watson SP Biochem J; 2002 Jan; 361(Pt 2):297-305. PubMed ID: 11772401 [TBL] [Abstract][Full Text] [Related]
47. [Effect of ASA on the interaction of von Willebrand factor with the platelet membrane]. Ferri A; Anello G; Calza R; Bozza A Boll Soc Ital Biol Sper; 1992 Oct; 68(10):607-12. PubMed ID: 1295515 [TBL] [Abstract][Full Text] [Related]
48. Influence of combined thrombin stimulation, surface activation, and receptor occupancy on organization of GPIb/IX receptors on human platelets. White JG; Krumwiede M; Cocking-Johnson D; Escolar G Br J Haematol; 1994 Sep; 88(1):137-48. PubMed ID: 7803236 [TBL] [Abstract][Full Text] [Related]
49. Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb/IIIa. Pareti FI; Federici AB; Cattaneo M; Mannucci PM Br J Haematol; 1990 May; 75(1):86-91. PubMed ID: 2375928 [TBL] [Abstract][Full Text] [Related]
50. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. McCrary JK; Nolasco LH; Hellums JD; Kroll MH; Turner NA; Moake JL Ann Biomed Eng; 1995; 23(6):787-93. PubMed ID: 8572428 [TBL] [Abstract][Full Text] [Related]
51. Functional analysis of a recombinant glycoprotein Ib alpha polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen. Cruz MA; Petersen E; Turci SM; Handin RI J Biol Chem; 1992 Jan; 267(2):1303-9. PubMed ID: 1730650 [TBL] [Abstract][Full Text] [Related]
52. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Pareti FI; Mazzucato M; Bottini E; Mannucci PM Br J Haematol; 1992 Sep; 82(1):81-6. PubMed ID: 1419806 [TBL] [Abstract][Full Text] [Related]
53. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction. Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052 [TBL] [Abstract][Full Text] [Related]
54. von Willebrand factor is present on the surface of platelets stimulated in plasma by ADP. Adelman B; Carlson P; Powers P Blood; 1987 Nov; 70(5):1362-6. PubMed ID: 2822171 [TBL] [Abstract][Full Text] [Related]
55. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor. Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601 [TBL] [Abstract][Full Text] [Related]
56. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked. Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936 [TBL] [Abstract][Full Text] [Related]
57. Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc gamma IIA receptor. Canobbio I; Bertoni A; Lova P; Paganini S; Hirsch E; Sinigaglia F; Balduini C; Torti M J Biol Chem; 2001 Jul; 276(28):26022-9. PubMed ID: 11344169 [TBL] [Abstract][Full Text] [Related]
58. von Willebrand factor (VWF)-dependent human platelet activation: porcine VWF utilizes different transmembrane signaling pathways than does thrombin to activate platelets, but both require protein phosphatase function. Song S; Mody M; Freedman J; Ellis J; Lazarus AH J Thromb Haemost; 2003 Feb; 1(2):337-46. PubMed ID: 12871509 [TBL] [Abstract][Full Text] [Related]
59. Purification and characterization of human platelet von Willebrand factor. Williams SB; McKeown LP; Krutzsch H; Hansmann K; Gralnick HR Br J Haematol; 1994 Nov; 88(3):582-91. PubMed ID: 7819071 [TBL] [Abstract][Full Text] [Related]
60. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. Moake JL; Turner NA; Stathopoulos NA; Nolasco LH; Hellums JD J Clin Invest; 1986 Dec; 78(6):1456-61. PubMed ID: 3491092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]